nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—SLC6A4—conduct disorder	0.5	0.565	CbGaD
Trimipramine—HTR2A—conduct disorder	0.385	0.435	CbGaD
Trimipramine—SLC6A2—autonomic nervous system—conduct disorder	0.00208	0.33	CbGeAlD
Trimipramine—HTR2A—autonomic nervous system—conduct disorder	0.00125	0.199	CbGeAlD
Trimipramine—Propiomazine—DRD4—conduct disorder	0.000534	0.0692	CrCbGaD
Trimipramine—Cyamemazine—HTR2A—conduct disorder	0.00048	0.0622	CrCbGaD
Trimipramine—Methotrimeprazine—DRD4—conduct disorder	0.000457	0.0592	CrCbGaD
Trimipramine—Cyclobenzaprine—HTR2A—conduct disorder	0.000446	0.0578	CrCbGaD
Trimipramine—Epinastine—HTR2A—conduct disorder	0.000443	0.0574	CrCbGaD
Trimipramine—Promazine—DRD4—conduct disorder	0.000396	0.0513	CrCbGaD
Trimipramine—Chlorpromazine—DRD4—conduct disorder	0.000348	0.0452	CrCbGaD
Trimipramine—Mianserin—SLC6A4—conduct disorder	0.000333	0.0432	CrCbGaD
Trimipramine—ADRA1B—brain—conduct disorder	0.000333	0.0529	CbGeAlD
Trimipramine—Acepromazine—HTR2A—conduct disorder	0.000308	0.0399	CrCbGaD
Trimipramine—Clomipramine—SLC6A4—conduct disorder	0.000305	0.0395	CrCbGaD
Trimipramine—HTR3A—brain—conduct disorder	0.0003	0.0476	CbGeAlD
Trimipramine—Nortriptyline—SLC6A4—conduct disorder	0.000298	0.0386	CrCbGaD
Trimipramine—Doxepin—SLC6A4—conduct disorder	0.000267	0.0346	CrCbGaD
Trimipramine—Mianserin—HTR2A—conduct disorder	0.000256	0.0332	CrCbGaD
Trimipramine—SLC6A3—brain—conduct disorder	0.000249	0.0396	CbGeAlD
Trimipramine—Propiomazine—HTR2A—conduct disorder	0.000246	0.0319	CrCbGaD
Trimipramine—Desipramine—SLC6A4—conduct disorder	0.000245	0.0318	CrCbGaD
Trimipramine—HTR1D—brain—conduct disorder	0.000243	0.0387	CbGeAlD
Trimipramine—HTR2C—brain—conduct disorder	0.000241	0.0383	CbGeAlD
Trimipramine—Clomipramine—HTR2A—conduct disorder	0.000234	0.0304	CrCbGaD
Trimipramine—Nortriptyline—HTR2A—conduct disorder	0.000229	0.0297	CrCbGaD
Trimipramine—SLC6A4—brain—conduct disorder	0.000228	0.0363	CbGeAlD
Trimipramine—HTR1A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000227	0.00225	CbGpPWpGaD
Trimipramine—HTR3A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000226	0.00224	CbGpPWpGaD
Trimipramine—HTR1A—GPCR ligand binding—CGA—conduct disorder	0.000221	0.00219	CbGpPWpGaD
Trimipramine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00022	0.00218	CbGpPWpGaD
Trimipramine—HTR2C—GPCR ligand binding—CGA—conduct disorder	0.00022	0.00218	CbGpPWpGaD
Trimipramine—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000218	0.00216	CbGpPWpGaD
Trimipramine—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.000216	0.00214	CbGpPWpGaD
Trimipramine—ADRA2B—G alpha (i) signalling events—DRD4—conduct disorder	0.000212	0.0021	CbGpPWpGaD
Trimipramine—Methotrimeprazine—HTR2A—conduct disorder	0.000211	0.0273	CrCbGaD
Trimipramine—ADRA1B—GPCR ligand binding—CGA—conduct disorder	0.000211	0.00209	CbGpPWpGaD
Trimipramine—Imipramine—SLC6A4—conduct disorder	0.000208	0.027	CrCbGaD
Trimipramine—Promethazine—HTR2A—conduct disorder	0.000208	0.0269	CrCbGaD
Trimipramine—Amitriptyline—SLC6A4—conduct disorder	0.000207	0.0268	CrCbGaD
Trimipramine—Doxepin—HTR2A—conduct disorder	0.000205	0.0266	CrCbGaD
Trimipramine—SLC6A3—Transmission across Chemical Synapses—COMT—conduct disorder	0.000205	0.00203	CbGpPWpGaD
Trimipramine—HTR1A—G alpha (i) signalling events—DRD4—conduct disorder	0.000204	0.00203	CbGpPWpGaD
Trimipramine—SLC6A3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000204	0.00202	CbGpPWpGaD
Trimipramine—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.000203	0.00202	CbGpPWpGaD
Trimipramine—HTR1A—brain—conduct disorder	0.000203	0.0322	CbGeAlD
Trimipramine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000203	0.00201	CbGpPWpGaD
Trimipramine—SLC6A2—brain—conduct disorder	0.000201	0.0319	CbGeAlD
Trimipramine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000201	0.00199	CbGpPWpGaD
Trimipramine—SLC6A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000198	0.00196	CbGpPWpGaD
Trimipramine—HRH1—IL-4 Signaling Pathway—EP300—conduct disorder	0.000198	0.00196	CbGpPWpGaD
Trimipramine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000197	0.00195	CbGpPWpGaD
Trimipramine—HTR2A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000196	0.00194	CbGpPWpGaD
Trimipramine—DRD2—GPCR ligand binding—CGA—conduct disorder	0.000194	0.00192	CbGpPWpGaD
Trimipramine—HTR2A—GPCR ligand binding—CGA—conduct disorder	0.000191	0.00189	CbGpPWpGaD
Trimipramine—HRH1—GPCR ligand binding—CGA—conduct disorder	0.000191	0.00189	CbGpPWpGaD
Trimipramine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00019	0.00188	CbGpPWpGaD
Trimipramine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000189	0.00187	CbGpPWpGaD
Trimipramine—Desipramine—HTR2A—conduct disorder	0.000188	0.0244	CrCbGaD
Trimipramine—ADRA1A—GPCR ligand binding—CGA—conduct disorder	0.000187	0.00185	CbGpPWpGaD
Trimipramine—ADRA1A—brain—conduct disorder	0.000187	0.0297	CbGeAlD
Trimipramine—HTR1A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000185	0.00183	CbGpPWpGaD
Trimipramine—DRD2—brain—conduct disorder	0.000183	0.0291	CbGeAlD
Trimipramine—Promazine—HTR2A—conduct disorder	0.000183	0.0237	CrCbGaD
Trimipramine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000181	0.00179	CbGpPWpGaD
Trimipramine—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.00018	0.00178	CbGpPWpGaD
Trimipramine—SLC6A3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000175	0.00174	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR ligand binding—CGA—conduct disorder	0.000174	0.00172	CbGpPWpGaD
Trimipramine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000168	0.00167	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—CGA—conduct disorder	0.000168	0.00166	CbGpPWpGaD
Trimipramine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000167	0.00165	CbGpPWpGaD
Trimipramine—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000166	0.00164	CbGpPWpGaD
Trimipramine—HTR1D—GPCR ligand binding—DRD4—conduct disorder	0.000166	0.00164	CbGpPWpGaD
Trimipramine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000164	0.00162	CbGpPWpGaD
Trimipramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000164	0.00162	CbGpPWpGaD
Trimipramine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000163	0.00161	CbGpPWpGaD
Trimipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000162	0.0016	CbGpPWpGaD
Trimipramine—ADRA2A—G alpha (i) signalling events—DRD4—conduct disorder	0.000161	0.00159	CbGpPWpGaD
Trimipramine—Chlorpromazine—HTR2A—conduct disorder	0.000161	0.0208	CrCbGaD
Trimipramine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000161	0.00159	CbGpPWpGaD
Trimipramine—Imipramine—HTR2A—conduct disorder	0.00016	0.0207	CrCbGaD
Trimipramine—HTR2C—G alpha (q) signalling events—HTR2A—conduct disorder	0.000159	0.00158	CbGpPWpGaD
Trimipramine—Amitriptyline—HTR2A—conduct disorder	0.000159	0.0206	CrCbGaD
Trimipramine—SLC6A3—Neuronal System—COMT—conduct disorder	0.000157	0.00156	CbGpPWpGaD
Trimipramine—SLC6A3—Neuronal System—MAOA—conduct disorder	0.000156	0.00155	CbGpPWpGaD
Trimipramine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000155	0.00153	CbGpPWpGaD
Trimipramine—ADRA1B—G alpha (q) signalling events—HTR2A—conduct disorder	0.000153	0.00151	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—CGA—conduct disorder	0.000152	0.00151	CbGpPWpGaD
Trimipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000149	0.00148	CbGpPWpGaD
Trimipramine—HRH1—brain—conduct disorder	0.000145	0.023	CbGeAlD
Trimipramine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000143	0.00141	CbGpPWpGaD
Trimipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000143	0.00141	CbGpPWpGaD
Trimipramine—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000142	0.00141	CbGpPWpGaD
Trimipramine—ADRA2A—brain—conduct disorder	0.000142	0.0226	CbGeAlD
Trimipramine—SLC6A4—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000141	0.0014	CbGpPWpGaD
Trimipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00014	0.00139	CbGpPWpGaD
Trimipramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00014	0.00139	CbGpPWpGaD
Trimipramine—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000138	0.00137	CbGpPWpGaD
Trimipramine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000138	0.00136	CbGpPWpGaD
Trimipramine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000136	0.00135	CbGpPWpGaD
Trimipramine—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.000135	0.00134	CbGpPWpGaD
Trimipramine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000132	0.00131	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—CGA—conduct disorder	0.000129	0.00128	CbGpPWpGaD
Trimipramine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000128	0.00127	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR ligand binding—DRD4—conduct disorder	0.000128	0.00127	CbGpPWpGaD
Trimipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000128	0.00127	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.000125	0.00124	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.000124	0.00123	CbGpPWpGaD
Trimipramine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000124	0.00123	CbGpPWpGaD
Trimipramine—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.000124	0.00123	CbGpPWpGaD
Trimipramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000124	0.00122	CbGpPWpGaD
Trimipramine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000123	0.00122	CbGpPWpGaD
Trimipramine—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.000123	0.00122	CbGpPWpGaD
Trimipramine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000121	0.0012	CbGpPWpGaD
Trimipramine—HTR2A—brain—conduct disorder	0.000121	0.0192	CbGeAlD
Trimipramine—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.000119	0.00118	CbGpPWpGaD
Trimipramine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000118	0.00117	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.000118	0.00117	CbGpPWpGaD
Trimipramine—CYP2C19—Biological oxidations—COMT—conduct disorder	0.000118	0.00117	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—CGA—conduct disorder	0.000118	0.00116	CbGpPWpGaD
Trimipramine—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.000117	0.00116	CbGpPWpGaD
Trimipramine—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.000116	0.00115	CbGpPWpGaD
Trimipramine—SLC6A4—Circadian rythm related genes—EP300—conduct disorder	0.000115	0.00114	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—CGA—conduct disorder	0.000113	0.00112	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—CGA—conduct disorder	0.000113	0.00112	CbGpPWpGaD
Trimipramine—CYP2D6—brain—conduct disorder	0.00011	0.0175	CbGeAlD
Trimipramine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00011	0.00109	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.00011	0.00109	CbGpPWpGaD
Trimipramine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000109	0.00108	CbGpPWpGaD
Trimipramine—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000109	0.00108	CbGpPWpGaD
Trimipramine—CYP2D6—Biological oxidations—COMT—conduct disorder	0.000108	0.00107	CbGpPWpGaD
Trimipramine—HTR1D—GPCR ligand binding—HTR2A—conduct disorder	0.000108	0.00107	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—CGA—conduct disorder	0.000108	0.00107	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.000108	0.00107	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—CGA—conduct disorder	0.000108	0.00107	CbGpPWpGaD
Trimipramine—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000108	0.00107	CbGpPWpGaD
Trimipramine—CYP2C9—Biological oxidations—COMT—conduct disorder	0.000107	0.00106	CbGpPWpGaD
Trimipramine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000107	0.00106	CbGpPWpGaD
Trimipramine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000107	0.00106	CbGpPWpGaD
Trimipramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000107	0.00106	CbGpPWpGaD
Trimipramine—HRH1—GPCR ligand binding—DRD4—conduct disorder	0.000107	0.00106	CbGpPWpGaD
Trimipramine—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.000107	0.00106	CbGpPWpGaD
Trimipramine—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000106	0.00105	CbGpPWpGaD
Trimipramine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000106	0.00105	CbGpPWpGaD
Trimipramine—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.000106	0.00105	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.000106	0.00105	CbGpPWpGaD
Trimipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000106	0.00105	CbGpPWpGaD
Trimipramine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000105	0.00104	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.000105	0.00104	CbGpPWpGaD
Trimipramine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000101	0.001	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0001	0.000993	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—CGA—conduct disorder	9.96e-05	0.000987	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	9.82e-05	0.000973	CbGpPWpGaD
Trimipramine—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	9.81e-05	0.000972	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—CGA—conduct disorder	9.8e-05	0.000971	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—CGA—conduct disorder	9.78e-05	0.000969	CbGpPWpGaD
Trimipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.73e-05	0.000964	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	9.73e-05	0.000964	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	9.6e-05	0.000951	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—DRD4—conduct disorder	9.38e-05	0.000929	CbGpPWpGaD
Trimipramine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.31e-05	0.000923	CbGpPWpGaD
Trimipramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.15e-05	0.000906	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	9.14e-05	0.000905	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CGA—conduct disorder	8.99e-05	0.00089	CbGpPWpGaD
Trimipramine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.97e-05	0.000889	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—CGA—conduct disorder	8.92e-05	0.000884	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	8.72e-05	0.000864	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—DRD4—conduct disorder	8.52e-05	0.000844	CbGpPWpGaD
Trimipramine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	8.48e-05	0.00084	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	8.37e-05	0.000829	CbGpPWpGaD
Trimipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.34e-05	0.000826	CbGpPWpGaD
Trimipramine—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	8.08e-05	0.0008	CbGpPWpGaD
Trimipramine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	8.04e-05	0.000796	CbGpPWpGaD
Trimipramine—ABCB1—brain—conduct disorder	7.92e-05	0.0126	CbGeAlD
Trimipramine—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	7.69e-05	0.000762	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	7.25e-05	0.000718	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—WASF1—conduct disorder	7.2e-05	0.000714	CbGpPWpGaD
Trimipramine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	7.09e-05	0.000703	CbGpPWpGaD
Trimipramine—CYP3A4—Biological oxidations—COMT—conduct disorder	7.08e-05	0.000702	CbGpPWpGaD
Trimipramine—CYP3A4—Biological oxidations—MAOA—conduct disorder	7.03e-05	0.000697	CbGpPWpGaD
Trimipramine—DRD2—Circadian rythm related genes—EP300—conduct disorder	7.03e-05	0.000697	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	7e-05	0.000693	CbGpPWpGaD
Trimipramine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	6.99e-05	0.000692	CbGpPWpGaD
Trimipramine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	6.96e-05	0.00069	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	6.96e-05	0.00069	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CGA—conduct disorder	6.94e-05	0.000688	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	6.83e-05	0.000677	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CGA—conduct disorder	6.7e-05	0.000664	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CGA—conduct disorder	6.67e-05	0.000661	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	6.66e-05	0.00066	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	6.58e-05	0.000652	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CGA—conduct disorder	6.38e-05	0.000632	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—DRD4—conduct disorder	6.35e-05	0.00063	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	6.35e-05	0.000629	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	6.32e-05	0.000626	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—CGA—conduct disorder	6.3e-05	0.000624	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	6.14e-05	0.000609	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	6.12e-05	0.000606	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	6.05e-05	0.0006	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	6.04e-05	0.000599	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	6.03e-05	0.000598	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	5.92e-05	0.000586	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CGA—conduct disorder	5.88e-05	0.000583	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CGA—conduct disorder	5.79e-05	0.000574	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CGA—conduct disorder	5.78e-05	0.000572	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CGA—conduct disorder	5.67e-05	0.000562	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—DRD4—conduct disorder	5.58e-05	0.000553	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—WASF1—conduct disorder	5.56e-05	0.000551	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	5.56e-05	0.000551	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	5.5e-05	0.000545	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	5.49e-05	0.000544	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—DRD4—conduct disorder	5.48e-05	0.000543	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	5.37e-05	0.000533	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—WASF1—conduct disorder	5.37e-05	0.000532	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—WASF1—conduct disorder	5.34e-05	0.000529	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CGA—conduct disorder	5.27e-05	0.000522	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—WASF1—conduct disorder	5.12e-05	0.000507	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—DRD4—conduct disorder	5.03e-05	0.000499	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	4.99e-05	0.000495	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	4.73e-05	0.000469	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—WASF1—conduct disorder	4.72e-05	0.000467	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—WASF1—conduct disorder	4.64e-05	0.00046	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—WASF1—conduct disorder	4.63e-05	0.000459	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	4.57e-05	0.000452	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	4.54e-05	0.00045	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	4.54e-05	0.00045	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	4.53e-05	0.000449	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CGA—conduct disorder	4.46e-05	0.000442	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CGA—conduct disorder	4.36e-05	0.000432	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	4.35e-05	0.000431	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	4.29e-05	0.000426	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—WASF1—conduct disorder	4.22e-05	0.000418	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	4.15e-05	0.000411	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	4.12e-05	0.000409	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CGA—conduct disorder	4.11e-05	0.000407	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CGA—conduct disorder	4.07e-05	0.000403	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	4.01e-05	0.000397	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—EP300—conduct disorder	3.96e-05	0.000393	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	3.95e-05	0.000391	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	3.94e-05	0.00039	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—DRD4—conduct disorder	3.89e-05	0.000385	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	3.86e-05	0.000383	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—DRD4—conduct disorder	3.75e-05	0.000372	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—DRD4—conduct disorder	3.73e-05	0.00037	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	3.64e-05	0.000361	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	3.59e-05	0.000356	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—DRD4—conduct disorder	3.57e-05	0.000354	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	3.57e-05	0.000354	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	3.51e-05	0.000347	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—DRD4—conduct disorder	3.3e-05	0.000327	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—HTR2A—conduct disorder	3.28e-05	0.000325	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	3.26e-05	0.000323	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—DRD4—conduct disorder	3.24e-05	0.000321	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—DRD4—conduct disorder	3.24e-05	0.000321	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	3.18e-05	0.000315	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—EP300—conduct disorder	3.01e-05	0.000298	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—DRD4—conduct disorder	2.95e-05	0.000292	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—COMT—conduct disorder	2.84e-05	0.000282	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—MAOA—conduct disorder	2.82e-05	0.00028	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CGA—conduct disorder	2.68e-05	0.000266	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	2.54e-05	0.000251	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—HTR2A—conduct disorder	2.45e-05	0.000243	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	2.44e-05	0.000241	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	2.33e-05	0.000231	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—HTR2A—conduct disorder	2.15e-05	0.000213	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—HTR2A—conduct disorder	2.11e-05	0.000209	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	2.07e-05	0.000205	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—COMT—conduct disorder	2.01e-05	0.0002	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—MAOA—conduct disorder	2e-05	0.000198	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—COMT—conduct disorder	1.97e-05	0.000195	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—MAOA—conduct disorder	1.95e-05	0.000193	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.94e-05	0.000192	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.92e-05	0.000191	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—COMT—conduct disorder	1.85e-05	0.000184	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—MAOA—conduct disorder	1.84e-05	0.000182	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—COMT—conduct disorder	1.84e-05	0.000182	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—MAOA—conduct disorder	1.82e-05	0.000181	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.77e-05	0.000175	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—EP300—conduct disorder	1.74e-05	0.000172	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—EP300—conduct disorder	1.34e-05	0.000133	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—EP300—conduct disorder	1.3e-05	0.000129	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—EP300—conduct disorder	1.29e-05	0.000128	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—EP300—conduct disorder	1.24e-05	0.000122	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—EP300—conduct disorder	1.22e-05	0.000121	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—COMT—conduct disorder	1.21e-05	0.00012	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—MAOA—conduct disorder	1.2e-05	0.000119	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—EP300—conduct disorder	1.14e-05	0.000113	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—EP300—conduct disorder	1.12e-05	0.000111	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—EP300—conduct disorder	1.12e-05	0.000111	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—EP300—conduct disorder	1.1e-05	0.000109	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—EP300—conduct disorder	1.02e-05	0.000101	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—EP300—conduct disorder	8.64e-06	8.56e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—EP300—conduct disorder	8.43e-06	8.36e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—EP300—conduct disorder	7.95e-06	7.87e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—EP300—conduct disorder	7.88e-06	7.81e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—EP300—conduct disorder	5.2e-06	5.15e-05	CbGpPWpGaD
